Silver Book Fact

To date, multiple genomewide comparisons of thousands of subjects with type 2 diabetes and controls without the disease have identified approximately twenty-five DNA variants that are significantly associated with type 2 diabetes. 

Spiegel A, Hawkins M. ‘Personalized Medicine’ To Identify Genetic Risks For Type 2 Diabetes And Focus Prevention: Can It Fulfill Its Promise?. Health Affairs. 2012; 31(1): 43-49. https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.2011.1054?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed

Reference

Title
‘Personalized Medicine’ To Identify Genetic Risks For Type 2 Diabetes And Focus Prevention: Can It Fulfill Its Promise?
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2012
Authors
Spiegel A, Hawkins M
Volume & Issue
Volume 31, Issue 1
Pages
43-49
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Improvements in key clinical measures over an average of 14.8 months in a community pharmacy health management program called the Diabetes Ten City Challenge, in which 573 patients with diabetes…  
  • Economics of DR Treatment
    Laser treatment plus a VEGF inhibitor achieved an incremental cost-effectiveness ratio of $12,410 per quality adjusted life year in patients with DME.  
  • Every additional dollar spent on statin therapy for diabetes patients without cardiovascular disease has produced health gains valued between $7 and $31.  
  • One economic model predicts that if type 1 and type 2 diabetics had begun Captopril (a drug that controls blood pressure and delays the onset of kidney failure) treatment in…  
  • Projected change in 3-year diabetes-related costs and 10-year disease event rates among Medicaid recipients participating in a diabetes self-management education program consisting of a 60 minute initial individual assessment of…